The Unit CURED aims to co-develop novel class of anti-cancer immunotherapy combining fundamental science on transcription factors and extracellular vesicles with translational approaches. The unit consists of more than twenty researchers and it is very well founded with both national and international research grants; Academy of Finland, Jane and Aatos Erkko Foundation, ERCs among others. Unit's principal investigators are listed below.